World Health Organization, R. O. f. S.-E. A. Viral hepatitis in the WHO South-East Asia Region. Available from, https://apps.who.int/iris/handle/10665/206521 (2011).
Hoofnagle, J. H., Nelson, K. E. & Purcell, R. H. Hepatitis E. N. Engl. J. Med. 367, 1237–1244 (2012).
Said, B. et al. Pork products associated with human infection caused by an emerging phylotype of hepatitis E virus in England and Wales. Epidemiol. Infect. 145, 2417–2423 (2017).
England, P. H. Hepatitis E: symptoms, transmission, treatment and prevention. Available from, https://www.gov.uk/government/publications/hepatitis-e-symptoms-transmission-prevention-treatment/hepatitis-e-symptoms-transmission-treatment-and-prevention (2019).
Pérez-Gracia, M. T., Mateos Lindemann, M. L. & Montalvo Villalba, M. C. Hepatitis E: current status. Rev. Med. Virol. 23, 384–398 (2013).
Doceul, V., Bagdassarian, E., Demange, A. & Pavio, N. Zoonotic hepatitis E virus: classification, animal reservoirs and transmission routes. Viruses 8, 270 (2016).
Kamar, N., Marion, O., Abravanel, F., Izopet, J. & Dalton, H. R. Extrahepatic manifestations of hepatitis E virus. Liver Int. 36, 467–472 (2016).
Ma, H. et al. Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses. PLoS ONE 5, e9160 (2010).
Maneerat, Y., Clayson, E. T., Myint, K. S., Young, G. D. & Innis, B. L. Experimental infection of the laboratory rat with the hepatitis E virus. J. Med. Virol. 48, 121–128 (1996).
Li, T.-C. et al. Mice are not susceptible to hepatitis E virus infection. J. Vet. Med. Sci. 70, 1359–1362 (2008).
McCaustland, K. et al. Hepatitis E virus infection in chimpanzees: a retrospective analysis. Adv. Virol. 145, 1909–1918 (2000).
Meng, X.-J. et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Adv. Virol. 143, 1405–1415 (1998).
Tang, Z.-M. et al. The Bama miniature swine is susceptible to experimental HEV infection. Sci. Rep. 6, 31813 (2016).
Jain, P., Nijhawan, S., Rai, R. R., Nepalia, S. & Mathur, A. Acute pancreatitis in acute viral hepatitis. World J. Gastroenterol. WJG 13, 5741 (2007).
Haffar, S., Bazerbachi, F., Garg, S., Lake, J. R. & Freeman, M. L. Frequency and prognosis of acute pancreatitis associated with acute hepatitis E: A systematic review. Pancreatology 15, 321–326 (2015).
Dalton, H. R. et al. Host risk factors and autochthonous hepatitis E infection. Eur. J. Gastroenterol. Hepatol. 23, 1200–1205 (2011).
Holla, P., Ahmad, I., Ahmed, Z. & Jameel, S. Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway. Traffic 16, 398–416 (2015).
Chang, K.-O. Role of cholesterol pathways in norovirus replication. J. Virol. 83, 8587–8595 (2009).
Osuna-Ramos, J. F., Reyes-Ruiz, J. M. & del Ángel, R. M. The role of host cholesterol during flavivirus infection. Front. Cell. Infect. Microbiol. 8, 2 (2018).
Sitohy, M. et al. The effect of bovine whey proteins on the ability of poliovirus and Coxsackie virus to infect Vero cell cultures. Int. Dairy J. 18, 658–668 (2008).
Bui, T. et al. Median infectious dose of human norovirus GII 4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age. J. Gen. Virol. 94, 2005–2016 (2013).
Jothikumar, N., Cromeans, T. L., Robertson, B. H., Meng, X. & Hill, V. R. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J. Virol. Methods 131, 65–71 (2006).
Lhomme, S. et al. Hepatitis E pathogenesis. Viruses 8, 212 (2016).
Drave, S. A. et al. Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells. J. Viral Hepatitis 23, 512–521 (2016).
Zhou, X. et al. Hepatitis E virus infects neurons and brains. J. Infect. Dis. 215, 1197–1206 (2017).
Tian, J. et al. Brain infection by hepatitis E virus probably via damage of the blood-brain barrier due to alterations of tight junction proteins. Front. Cell. Infect. Microbiol. 9, 2 (2019).
Pischke, S. et al. Hepatitis E virus: Infection beyond the liver?. J. Hepatol. 66, 1082–1095 (2017).
Panepinto, L., Phillips, R., Wheeler, L. & Will, D. The Yucatan minature pig as a laboratory animal. Lab. Anim. Sci. 28, 308–313 (1978).
Meurens, F., Summerfield, A., Nauwynck, H., Saif, L. & Gerdts, V. The pig: a model for human infectious diseases. Trends Microbiol. 20, 50–57 (2012).
Deniel, C. et al. Acute pancreatitis: A rare complication of acute hepatitis E. J. Clin. Virol. 51, 202–204 (2011).
Kanno, H., Ozawa, H., Tateda, S., Yahata, K. & Itoi, E. Upregulation of the receptor-interacting protein 3 expression and involvement in neural tissue damage after spinal cord injury in mice. BMC Neurosci. 16, 62 (2015).
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P. & Kroemer, G. The molecular machinery of regulated cell death. Cell Res. 1, 2 (2019).
Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311 (2015).
Pobezinskaya, Y. L. & Liu, Z. The role of TRADD in death receptor signaling. Cell Cycle 11, 871–876 (2012).
Wang, G., Qu, F.-Z., Li, L., Lv, J.-C. & Sun, B. Necroptosis: A potential, promising target and switch in acute pancreatitis. Apoptosis 21, 121–129 (2016).
Meng, X. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet. Microbiol. 140, 256–265 (2010).
Gupta, P. et al. Immunohistochemistry for the diagnosis of hepatitis E virus infection. J. Viral Hepatitis 19, 2 (2012).
Ha, S. K. & Chae, C.-H. Immunohistochemistry for the detection of swine hepatitis E virus in the liver. J. Viral Hepatitis 11, 263–267 (2004).
Han, J. et al. SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitis. PLoS ONE 9, e99861 (2014).
Lenggenhager, D. et al. Visualization of hepatitis E virus RNA and proteins in the human liver. J. Hepatol. 67, 471–479 (2017).
Das, R. & Tripathy, A. Increased expressions of NKp44, NKp46 on NK/NKT-like cells are associated with impaired cytolytic function in self-limiting hepatitis E infection. Med. Microbiol. Immunol. 203, 303–314 (2014).
Kyrylkova, K., Kyryachenko, S., Leid, M. & Kioussi, C. Odontogenesis 41–47 (Springer, Berlin, 2012).
Weber, K., Roelandt, R., Bruggeman, I., Estornes, Y. & Vandenabeele, P. Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis. Commun. Biol. 1, 6 (2018).
Majumdar, M., Singh, M. P., Goyal, K., Chawla, Y. & Ratho, R. K. Detailed investigation of ongoing subclinical hepatitis E virus infections; occurring in outbreak settings of North India. Liver Int. 35, 826–833 (2015).
Liver, E. A. EASL clinical practice guidelines on hepatitis E virus infection. J. Hepatol. 68, 1256–1271 (2018).
Choi, C. & Chae, C. Localization of swine hepatitis E virus in liver and extrahepatic tissues from naturally infected pigs by in situ hybridization. J. Hepatol. 38, 827–832 (2003).
Geng, Y. et al. Detection and assessment of infectivity of hepatitis E virus in urine. J. Hepatol. 64, 37–43 (2016).
Williams, T. P. E. et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J. Clin. Microbiol. 39, 3040–3046 (2001).
Shi, R. et al. Evidence of hepatitis E virus breaking through the blood–brain barrier and replicating in the central nervous system. J. Viral Hepatitis 23, 930–939 (2016).
Srivastava, R., Aggarwal, R., Bhagat, M., Chowdhury, A. & Naik, S. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J. Viral Hepatitis 15, 910–916 (2008).
Oliviero, B. et al. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity. J. Hepatol. 66, 1130–1137 (2017).
Hodgkinson, C. P. & Ye, S. Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression. Pharmacogenet. Genom. 18, 803–813 (2008).
Kim, Y. C., Kim, K. K. & Shevach, E. M. Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-β signal transduction. Immunology 130, 484–493 (2010).
Youssef, S. et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420, 78–84 (2002).
Jung, K. et al. The effects of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals. PLoS ONE 7, e41619 (2012).